CE Mark for eZono 4000 Tablet Ultrasound System with eZGuide

German “tablet” ultrasound specialist eZono AG, has received CE marking for its eZono 4000 system, with eZGuide, a revolutionary needle guidance technology, promising enhanced patient safety and procedural efficiency when placing central lines.


Ultrasound guidance for Central Line Placement, Regional Anaesthesia and Pain Management is a rapidly expanding market worldwide. Due to the impact on patient safety and efficiency

The eZono 4000 is designed specifically for procedural ultrasound and features the company’s proprietary eZGuide technology, the first freehand navigation system to visualize the position of the needle and location of the needle tip in real time, without the need for special needles or additional equipment.

Company comments

“We are very excited to bring this advanced imaging and needle guidance technology to the market”, said Graham Cox, CEO of eZono., “Until now, identifying the needle, especially the needle tip when performing ultrasound guidance has been very challenging. The eZono 4000 delivers a combination of powerful features, enabling point of care clinicians to perform procedures with greater accuracy, increased confidence and having the ability to clearly identify the position of the needle tip”. Existing technologies are very limited and can add significant costs to each procedure, due to the requirement of specific additional equipment and/or special needles.

“When designing eZGuide, we studied at length the real life everyday problems faced by clinicians when performing point of care procedures, and consideration of the mounting costs endured by healthcare providers worldwide” explained Eliseo Sobrino, Chief Technology Officer. “We want to deliver a product that offers increased safety without changing established protocols whilst reducing costs. I believe we have achieved that goal with the eZono 4000”.

Source: eZono AG., Business Wire

Share your thoughts

Your email address will not be published. Required fields are marked *